HEPATIC TM6SF2 SUPRRESSES NAFLD-HCC THROUGH ACTIVATING ANTITUMOR IMMUNITY

被引:0
|
作者
Zhang, Yating
Xie, Mingxu
Liu, Weixin
Liang, Cong
Wen, Jun
Yu, Jun
Zhang, Xiang
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1559
引用
收藏
页码:S1414 / S1414
页数:1
相关论文
共 50 条
  • [21] Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2
    Zhou, You
    Llaurado, Gemma
    Oresic, Matej
    Hyotylainen, Tuulia
    Orho-Melander, Marju
    Yki-Jarvinen, Hannele
    JOURNAL OF HEPATOLOGY, 2015, 62 (03) : 657 - 663
  • [22] Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: results of a case–control study
    I. P. Kalafati
    M. Dimitriou
    D. Borsa
    J. Vlachogiannakos
    K. Revenas
    A. Kokkinos
    S. D. Ladas
    G. V. Dedoussis
    European Journal of Nutrition, 2019, 58 : 1463 - 1473
  • [23] MECHANISTIC STUDY OF TM6SF2 IN NAFLD PATHOGENESIS: STABLY TRANSFECTED Huh7 CELLS OVER-EXPRESSING THE TM6SF2 E167K VARIANT EXHIBIT GREATER LEVELS OF OXIDATIVE STRESS
    Palmer, J.
    Liu, Y. -L.
    Day, C. P.
    Daly, A.
    Anstee, Q. M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S223 - S223
  • [24] Ligand Discovery for TM6SF2, a Novel Target for Liver Disease
    Reevey, Liatris
    Alon, Assaf
    Yang, Yixi
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2025, 392 (03):
  • [25] ROLE OF PNPLA3, TM6SF2 AND GCKR POLYMORPHISMS IN HEPATIC STEATOSIS IN WILSON'S DISEASE
    Loddo, E.
    Giglio, C.
    Civolani, A.
    Sorbello, O.
    Mocci, S.
    Mancuso, G.
    Faa, G.
    Onali, S.
    Giglio, S. R.
    Fantini, M. C.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S147 - S147
  • [26] Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis
    Ehrhardt, Nicole
    Doche, Michael E.
    Chen, Shuang
    Mao, Hui Z.
    Walsh, Meghan T.
    Bedoya, Candy
    Guindi, Maha
    Xiong, Weidong
    Irudayam, Joseph Ignatius
    Iqbal, Jahangir
    Fuchs, Sebastien
    French, Samuel W.
    Hussain, M. Mahmood
    Arditi, Moshe
    Arumugaswami, Vaithilingaraja
    Peterfy, Miklos
    HUMAN MOLECULAR GENETICS, 2017, 26 (14) : 2719 - 2731
  • [27] eIdentification of deleterious rare variants in MTTP, PNPLA3, and TM6SF2 in Japanese males and association studies with NAFLD
    Boonvisut, Supichaya
    Yoshida, Ken
    Nakayama, Kazuhiro
    Watanabe, Kazuhisa
    Miyashita, Hiroshi
    Iwamoto, Sadahiko
    LIPIDS IN HEALTH AND DISEASE, 2017, 16
  • [28] TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content
    Mahdessian, Hovsep
    Taxiarchis, Apostolos
    Popov, Sergej
    Silveira, Angela
    Franco-Cereceda, Anders
    Hamsten, Anders
    Eriksson, Per
    van't Hooft, Ferdinand
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (24) : 8913 - 8918
  • [29] Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: results of a case-control study
    Kalafati, I. P.
    Dimitriou, M.
    Borsa, D.
    Vlachogiannakos, J.
    Revenas, K.
    Kokkinos, A.
    Ladas, S. D.
    Dedoussis, G. V.
    EUROPEAN JOURNAL OF NUTRITION, 2019, 58 (04) : 1463 - 1473
  • [30] Identification of deleterious rare variants in MTTP, PNPLA3, and TM6SF2 in Japanese males and association studies with NAFLD
    Supichaya Boonvisut
    Ken Yoshida
    Kazuhiro Nakayama
    Kazuhisa Watanabe
    Hiroshi Miyashita
    Sadahiko Iwamoto
    Lipids in Health and Disease, 16